Bind Research is founded
January 9, 2025
Bind
Bind Research has officially incorporated, marking a significant milestone as it embarks on its mission to drive breakthrough advancements targeting intrinsically disordered proteins.
January 9, 2025
Bind
Bind Research has officially incorporated, marking a significant milestone as it embarks on its mission to drive breakthrough advancements targeting intrinsically disordered proteins.
Bind Research is joining the buzzing Cambridge scene! We have opened a satellite lab within the Milner Bio-Incubator at the Milner Therapeutics Institute in Cambridge. The Milner was set up to bridge academia and industry in drug discovery, bringing together its own research programme in functional genomics and target discovery with a consortium of pharma […]
20 May 2026
We’re happy to share that Rashik Aryal, MSc is the latest addition to the Bind Research family! Rashik joins us as Research Assistant, bringing a genuinely multidisciplinary background, from clinical diagnostics to genetic engineering to early-stage protein research. Rashik will be supporting Bind across protein expression and characterisation workflows, while also helping us develop rigorous, […]
1 May 2026
We’re delighted to welcome Mark Murcko, Ph.D. to the Board of Bind Research and our Lead Scientific Advisor. Mark joins Tom Kalil, who was recently appointed Interim Chair of the Board. Tom is CEO of Renaissance Philanthropy, an organisation that has already played a vital role in Bind’s establishment. Mark brings to Bind a deep […]
28 Apr 2026